BioWorld MedTech

May 9, 2012

NewCo on the Block: MID secures bridge financing, prepares for first-in-man trial

The market for percutaneous catheter-based heart procedures such as transcatheter aortic valve replacement (TAVR) has been developing at a rapid pace, but vascular access and closure devices have not been able to keep up. Read More

St. Jude Medical gains FDA approval for Assura portfolio

Report from Europe: Truer Medical earns CE mark for range of medical devices

Washington roundup: Upton: White House will see FDA user fee bill by July 4

Financings roundup: Select Medical commences $365M placement of notes

Agreements/contracts: Luna Innovations, Philips to build new robotic device

HIT roundup: Telit cellular module to connect CardioNet MCOT

Restructuring roundup: HearUSA's amended plan of liquidation accepted

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...